“UPL Corporation Ltd, a wholly owned subsidiary of agrochemical solutions provider UPL Ltd, has signed a definitive agreement with Platform Specialty Products Corporation to acquire Arysta LifeScience Inc, a global provider of innovative crop protection solutions, and its subsidiaries for approximately $4.2billion in cash, the company said in a filing to stock exchanges on Friday. The transaction is subject to customary closing conditions and regulatory approvals, it said. Sovereign wealth fund Abu Dhabi Investment Authority (ADIA), and leading global alternative asset firm TPG, have partnered to support UPL Corp’s planned acquisition of Arysta LifeScience,” reported Mint.

J Sagar Associates (JSA) acted for UPL, led by partner Lalit Kumar, principal associate Bharati Joshi and associates Amandeep Singh Virk and Priyanka Murali. The finance team assisting on the deal was led by partners Aashit Shah and Utsav Johri, and senior associate Kasturi Verma, according to a JSA release.

Jones Day acted as the overseas legal counsel to UPL.

Platinum Partners and Cleary Gottlieb were acting as legal advisers to Arysta LifeScience and global asset firm TPG.

Greenberg Traurig acted as legal counsel to Platform Specialty Products Corporation.

Credit Suisse is acting as financial advisor to Abu Dhabi Investment Authority (ADIA) and TPG.

UBS Investment Bank and Barclays are acting as financial advisors to Platform.

Evercore is acting as lead financial advisor to UPL Corp on the acquisition.

J.P. Morgan is also acting as financial advisor on the acquisition and acting as the exclusive financial advisor to UPL Corp for the proposed equity investment.

This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.